Molecule Information
General Information of the Molecule (ID: Mol01036)
Name |
Penicillin-binding protein 1A (PBP1A)
,Streptococcus pneumoniae
|
||||
---|---|---|---|---|---|
Synonyms |
PBP-1A; Exported protein 2; Peptidoglycan TGase; DD-transpeptidase; exp2; ponA; spr0329
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
pbpA
|
||||
Gene ID | |||||
Sequence |
MNKPTILRLIKYLSISFLSLVIAAIVLGGGVFFYYVSKAPSLSESKLVATTSSKIYDNKN
QLIADLGSERRVNAQANDIPTDLVKAIVSIEDHRFFDHRGIDTIRILGAFLRNLQSNSLQ GGSALTQQLIKLTYFSTSTSDQTISRKAQEAWLAIQLEQKATKQEILTYYINKVYMSNGN YGMQTAAQNYYGKDLNNLSLPQLALLAGMPQAPNQYDPYSHPEAAQDRRNLVLSEMKNQG YISAEQYEKAVNTPITDGLQSLKSASNYPAYMDNYLKEVINQVEEETGYNLLTTGMDVYT NVDQEAQKHLWDIYNTDEYVAYPDDELQVASTIVDVSNGKVIAQLGARHQSSNVSFGINQ AVETNRDWGSTMKPITDYAPALEYGVYESTATIVHDEPYNYPGTNTPVYNWDRGYFGNIT LQYALQQSRNVPAVETLNKVGLNRAKTFLNGLGIDYPSIHYSNAISSNTTESDKKYGASS EKMAAAYAAFANGGTYYKPMYIHKVVFSDGSEKEFSNVGTRAMKETTAYMMTDMMKTVLS YGTGRNAYLAWLPQAGKTGTSNYTDEEIENHIKTSQFVAPDELFAGYTRKYSMAVWTGYS NRLTPLVGNGLTVAAKVYRSMMTYLSEGSNPEDWNIPEGLYRNGEFVFKNGARSTWSSPA PQQPPSTESSSSSSDSSTSQSSSTTPSTNNSTTTNPNNNTQQSNTTPDQQNQNPQPAQP Click to Show/Hide
|
||||
Function |
Cell wall formation.
Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
ADTT: Aberration of the Drug's Therapeutic Target
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
Amoxicillin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Streptococcus pneumoniae infection | [1] | |||
Resistant Disease | Streptococcus pneumoniae infection [ICD-11: AA80.2] | |||
Resistant Drug | Amoxicillin | |||
Molecule Alteration | Missense mutation | p.S351A |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Streptococcus pneumoniae isolates | 1313 | ||
Experiment for Molecule Alteration |
PCR amplification and sequence alignments assay | |||
Experiment for Drug Resistance |
Correspondence discriminant assay | |||
Mechanism Description | The efficacy of Beta-lactam antibiotics in Streptococcus pneumoniae has been compromised because of the development of altered penicillin-binding proteins (PBPs). | |||
Disease Class: Streptococcus pneumoniae infection | [1] | |||
Resistant Disease | Streptococcus pneumoniae infection [ICD-11: AA80.2] | |||
Resistant Drug | Amoxicillin | |||
Molecule Alteration | Missense mutation | p.S575T |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Streptococcus pneumoniae isolates | 1313 | ||
Experiment for Molecule Alteration |
PCR amplification and sequence alignments assay | |||
Experiment for Drug Resistance |
Correspondence discriminant assay | |||
Mechanism Description | The efficacy of Beta-lactam antibiotics in Streptococcus pneumoniae has been compromised because of the development of altered penicillin-binding proteins (PBPs). | |||
Disease Class: Streptococcus pneumoniae infection | [1] | |||
Resistant Disease | Streptococcus pneumoniae infection [ICD-11: AA80.2] | |||
Resistant Drug | Amoxicillin | |||
Molecule Alteration | Missense mutation | p.N609D |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Streptococcus pneumoniae isolates | 1313 | ||
Experiment for Molecule Alteration |
PCR amplification and sequence alignments assay | |||
Experiment for Drug Resistance |
Correspondence discriminant assay | |||
Mechanism Description | The efficacy of Beta-lactam antibiotics in Streptococcus pneumoniae has been compromised because of the development of altered penicillin-binding proteins (PBPs). | |||
Disease Class: Streptococcus pneumoniae infection | [1] | |||
Resistant Disease | Streptococcus pneumoniae infection [ICD-11: AA80.2] | |||
Resistant Drug | Amoxicillin | |||
Molecule Alteration | Missense mutation | p.E512K |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Streptococcus pneumoniae isolates | 1313 | ||
Experiment for Molecule Alteration |
PCR amplification and sequence alignments assay | |||
Experiment for Drug Resistance |
Correspondence discriminant assay | |||
Mechanism Description | The efficacy of Beta-lactam antibiotics in Streptococcus pneumoniae has been compromised because of the development of altered penicillin-binding proteins (PBPs). |
Ceftobiprole
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Community-acquired pneumonia | [2], [3], [4] | |||
Resistant Disease | Community-acquired pneumonia [ICD-11: CA40.2] | |||
Resistant Drug | Ceftobiprole | |||
Molecule Alteration | Missense mutation | STMK motif p.T >A +SRNVP motif p.P >T |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Streptococcus pneumoniae isolates | 1313 | ||
Experiment for Molecule Alteration |
Genome sequence assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | Beta-Lactam resistance in S. pneumoniae is caused by mutations in the penicillin-binding domains of one or more of its six penicillin-binding proteins (PBPs) resulting from point mutations or mosaic genes. Altered PBP 1a, PBP 2x, and PBP 2b are the most important PBPs for Beta-lactam resistance among clinical isolates. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.